Unknown OBSERVATIONAL NCT03473444

Prevalence of Hyperuricemia in Pakistan

Sponsor: OBS Pakistan

Updated 6 times since 2018 Last updated: Mar 15, 2018 Started: Mar 1, 2018 Primary completion: Apr 1, 2018 Completion: Apr 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03473444, this observational or N/A phase trial focuses on Hyperuricemia and remains ongoing. Sponsored by OBS Pakistan, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Apr 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Apr 2020 [monthly]

Recruiting

▶ Show 1 earlier version

Apr 2018 — Jun 2018 [monthly]

Recruiting

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

OBS Pakistan

Data source: OBS Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mirpur, Pakistan